Viktor Kharitonin
$7.9B
Born
Nov 20, 1972
Age
53
Source of Wealth
Pharmaceuticals
Residence
Moscow,
Citizenship
Russia
Marital Status
Married
Children
2
Education
Master of Science, Novosibirsk State University
- Viktor Kharitonin created multinational pharmaceutical firm Pharmstandard with Russian billionaire Roman Abramovich and other partners in 2003 by combining five factories.
- Kharitonin and partner Egor Kulkov bought out the other investors in 2008, a year after Pharmstandard went public in London. They took Pharmstandard private again, eight years later.
- Kharitonin and Kulkov also hold stakes in other Russian pharmaceuticals companies: OTCPharm, Biocad and Generium, one of the producers of the COVID-19 vaccine Sputnik V.
- In 2022 The two partners tried to buy Russian assets of Austrian-British packaging and paper group Mondi for 1.5 billion euro, but Russian authorities rejected the deal.
- In 2023 Kharitonin and his partners bought Russian assets of German chemical producer Henkel for 600 million euros, leaving Henkel the option of buying back the business.
- In October 2014 Kharitonin became co-owner of Nurbugring in Germany, one of the oldest race tracks in Europe.
- The Novosibirsk State University graduate got his start selling consumer goods.
| Exchange | Ticker | Company Name | Number Of Shares | Share Price | Currency Code |
|---|